A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Pancreatic Cancer
Related studies linked through entity extraction aliases.
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions
- Status
- COMPLETED
- Phase
- N/A
Olaparib in PALB2 Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Study of OB-002 in Patients With Refractory Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma
- Status
- RECRUITING
- Phase
- NA
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2